ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

C Buske, M Hutchings, M Ladetto, V Goede, U Mey, P Soubeyran, M Spina, R Stauder, M Trnený, U Wedding, P Fields, ESMO Lymphoma Consensus Conference Panel Members, Stefano Luminari

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aim of the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in this manuscript.

Original languageEnglish
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
DOIs
Publication statusE-pub ahead of print - Nov 29 2017

Fingerprint

Medical Oncology
Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Peripheral T-Cell Lymphoma
Literature
Mantle-Cell Lymphoma
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Manuscripts
B-Cell Lymphoma
Switzerland
Practice Guidelines
Quality of Life

Keywords

  • Journal Article

Cite this

ESMO Consensus Conference on malignant lymphoma : general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. / Buske, C; Hutchings, M; Ladetto, M; Goede, V; Mey, U; Soubeyran, P; Spina, M; Stauder, R; Trnený, M; Wedding, U; Fields, P; ESMO Lymphoma Consensus Conference Panel Members; Luminari, Stefano.

In: Annals of oncology : official journal of the European Society for Medical Oncology, 29.11.2017.

Research output: Contribution to journalArticle

Buske, C ; Hutchings, M ; Ladetto, M ; Goede, V ; Mey, U ; Soubeyran, P ; Spina, M ; Stauder, R ; Trnený, M ; Wedding, U ; Fields, P ; ESMO Lymphoma Consensus Conference Panel Members ; Luminari, Stefano. / ESMO Consensus Conference on malignant lymphoma : general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2017.
@article{34d5006e20f9407195af00743f988df7,
title = "ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma",
abstract = "The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aim of the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in this manuscript.",
keywords = "Journal Article",
author = "C Buske and M Hutchings and M Ladetto and V Goede and U Mey and P Soubeyran and M Spina and R Stauder and M Trnen{\'y} and U Wedding and P Fields and {ESMO Lymphoma Consensus Conference Panel Members} and Stefano Luminari",
note = "{\circledC} The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.",
year = "2017",
month = "11",
day = "29",
doi = "10.1093/annonc/mdx413",
language = "English",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",

}

TY - JOUR

T1 - ESMO Consensus Conference on malignant lymphoma

T2 - general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

AU - Buske, C

AU - Hutchings, M

AU - Ladetto, M

AU - Goede, V

AU - Mey, U

AU - Soubeyran, P

AU - Spina, M

AU - Stauder, R

AU - Trnený, M

AU - Wedding, U

AU - Fields, P

AU - ESMO Lymphoma Consensus Conference Panel Members

AU - Luminari, Stefano

N1 - © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

PY - 2017/11/29

Y1 - 2017/11/29

N2 - The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aim of the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in this manuscript.

AB - The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aim of the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in this manuscript.

KW - Journal Article

U2 - 10.1093/annonc/mdx413

DO - 10.1093/annonc/mdx413

M3 - Article

C2 - 29194473

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -